The chemotherapy of intracerebral vs subcutaneous murine gliomas. A comparative study of the effect of VM 26.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000401:mortality; D004273:DNA, Neoplasm / Q000096:biosynthesis; D004195:Disease Models, Animal; D004806:Ependymoma / Q000188:drug therapy* / Q000378:metabolism / Q000401:mortality; D006027:Glycosides / Q000627:therapeutic use; D007267:Injections; D007279:Injections, Subcutaneous; D051379:Mice; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000378:metabolism / Q000401:mortality; D011034:Podophyllotoxin / Q000627:therapeutic use*; D013876:Thiophenes / Q000627:therapeutic use; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D006027:Glycosides; D013876:Thiophenes; D014316:Tritium; D011034:Podophyllotoxin; D013936:Thymidine